Literature DB >> 31570768

Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon.

Juan Putra1,2, Linda D Ferrell3, Annette S H Gouw4, Valerie Paradis5, Arvind Rishi6, Christine Sempoux7, Charles Balabaud8, Swan N Thung9, Paulette Bioulac-Sage8,10.   

Abstract

The molecular classification of hepatocellular adenomas highlights a distinctive genotype-phenotype correlation. Malignant transformation is an exceptionally rare complication of hepatocyte nuclear factor 1α (HNF1A)-inactivated hepatocellular adenomas. This subtype is characterized by loss of liver fatty acid binding protein immunoexpression. In this study, we characterized the histopathologic spectrum of 13 liver fatty acid binding protein-deficient hepatocellular adenoma cases showing malignant transformation from multiple centers. Clinicopathologic characteristics of these patients were evaluated. Stains for reticulin, liver fatty acid binding protein, beta-catenin and glutamine synthetase were applied to these lesions. Moreover, the findings were compared to patients with β-catenin mutated hepatocellular adenoma. Liver fatty acid binding protein-deficient hepatocellular adenomas with borderline features/carcinoma were seen predominantly in females (77%) with an average age of 46 ± 18 years and multiple lesions (77%; five patients with adenomatosis). Meanwhile, β-catenin mutated hepatocellular adenoma patients with malignant transformation were predominantly male (67%, p = 0.018) with single lesion (86%, p = 0.0009). The largest liver fatty acid binding protein-deficient hepatocellular adenoma nodule in each patient ranged from 4 to 15.5 cm. Loss of liver fatty acid binding protein by immunohistochemistry was noted in all adenoma and borderline/carcinoma components. Features of malignant transformation were pseudoglandular architecture (85%), cytologic atypia (85%), architectural atypia (100%) and lack of steatosis (100%). Other findings included myxoid change (39%), peliosis (46%) and sinusoidal dilatation (46%). Molecular studies confirmed somatic inactivation of HNF1A in 3 cases and absence of TERT promotor and exon 3 CTNNB1 mutations in five cases. To summarize, liver fatty acid binding protein-deficient hepatocellular adenoma with malignant transformation is most frequently seen in female patients with multiple lesions. Most of these lesions demonstrate pseudoglandular architecture, cytologic and architectural atypia, with lack of steatosis. The natural history of these lesions is relatively benign with the exception of disease recurrence in 1 patient.

Entities:  

Year:  2019        PMID: 31570768     DOI: 10.1038/s41379-019-0374-x

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  41 in total

Review 1.  Update on precursor and early lesions of hepatocellular carcinomas.

Authors:  Young Nyun Park
Journal:  Arch Pathol Lab Med       Date:  2011-06       Impact factor: 5.534

2.  Subtype classification of hepatocellular adenoma.

Authors:  Paulette Bioulac-Sage; Charles Balabaud; Jessica Zucman-Rossi
Journal:  Dig Surg       Date:  2010-04-01       Impact factor: 2.588

3.  Hepatocellular adenoma with malignant transformation in a patient with neonatal portal vein thrombosis.

Authors:  Lionel Arrivé; Jessica Zucman-Rossi; Pierre Balladur; Dominique Wendum
Journal:  Hepatology       Date:  2016-05-27       Impact factor: 17.425

4.  Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGA.

Authors:  Jaclyn F Hechtman; Ghassan K Abou-Alfa; Zsofia K Stadler; Diana L Mandelker; Michael H A Roehrl; Ahmet Zehir; Efsevia Vakiani; Sumit Middha; David S Klimstra; Jinru Shia
Journal:  Hum Pathol       Date:  2018-08-17       Impact factor: 3.466

5.  Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.

Authors:  Jessica Zucman-Rossi; Emmanuelle Jeannot; Jeanne Tran Van Nhieu; Jean-Yves Scoazec; Catherine Guettier; Sandra Rebouissou; Yannick Bacq; Emmanuelle Leteurtre; Valérie Paradis; Sophie Michalak; Dominique Wendum; Laurence Chiche; Monique Fabre; Lucille Mellottee; Christophe Laurent; Christian Partensky; Denis Castaing; Elie Serge Zafrani; Pierre Laurent-Puig; Charles Balabaud; Paulette Bioulac-Sage
Journal:  Hepatology       Date:  2006-03       Impact factor: 17.425

6.  Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.

Authors:  Jean-Charles Nault; Gabrielle Couchy; Charles Balabaud; Guillaume Morcrette; Stefano Caruso; Jean-Frederic Blanc; Yannick Bacq; Julien Calderaro; Valérie Paradis; Jeanne Ramos; Jean-Yves Scoazec; Viviane Gnemmi; Nathalie Sturm; Catherine Guettier; Monique Fabre; Eric Savier; Laurence Chiche; Philippe Labrune; Janick Selves; Dominique Wendum; Camilla Pilati; Alexis Laurent; Anne De Muret; Brigitte Le Bail; Sandra Rebouissou; Sandrine Imbeaud; Paulette Bioulac-Sage; Eric Letouzé; Jessica Zucman-Rossi
Journal:  Gastroenterology       Date:  2016-12-07       Impact factor: 22.682

7.  Beta-endorphin: interaction with specific nonopioid binding sites on EL4 thymoma cells.

Authors:  L Schweigerer; W Schmidt; H Teschemacher; S Wilhelm
Journal:  Neuropeptides       Date:  1985-09       Impact factor: 3.286

8.  Hepatocellular Carcinoma Arising in an HNF-1α-Mutated Adenoma in a 23-Year-Old Woman with Maturity-Onset Diabetes of the Young: A Case Report.

Authors:  Ashley E Stueck; Zhenhong Qu; Mary Ann Y Huang; Genís Campreciós; Linda D Ferrell; Swan N Thung
Journal:  Semin Liver Dis       Date:  2015-12-16       Impact factor: 6.115

Review 9.  Update on the new classification of hepatic adenomas: clinical, molecular, and pathologic characteristics.

Authors:  Sadhna Dhingra; M Isabel Fiel
Journal:  Arch Pathol Lab Med       Date:  2014-08       Impact factor: 5.534

10.  Giant hepatocellular carcinoma with bone metastasis in a young adult, emerged from pigmented adenoma with beta-Catenin activation: A case report.

Authors:  Sebastian Lünse; Paula Döring; Claus-Dieter Heidecke; Lars Ivo Partecke
Journal:  Int J Surg Case Rep       Date:  2017-05-03
View more
  8 in total

1.  Guidelines for the Treatment of Hepatocellular Adenoma in the Era of Molecular Biology: An Experience-Based Surgeons' Perspective.

Authors:  Paulo Herman; Gilton Marques Fonseca; Jaime Arthur Pirola Kruger; Vagner Birk Jeismann; Fabricio Ferreira Coelho
Journal:  J Gastrointest Surg       Date:  2020-07-14       Impact factor: 3.452

2.  Hepatic Adenomas in Patients 60 and Older Are Enriched for HNF1A Inactivation and Malignant Transformation.

Authors:  Saba Yasir; Zongming E Chen; Dhanpat Jain; Sanjay Kakar; Tsung-Teh Wu; Matthew M Yeh; Michael S Torbenson
Journal:  Am J Surg Pathol       Date:  2022-04-06       Impact factor: 6.298

3.  Hepatocellular adenoma: Where are we now?

Authors:  Xi Wang; Xuchen Zhang
Journal:  World J Gastroenterol       Date:  2022-04-14       Impact factor: 5.374

Review 4.  Hepatocellular adenoma in the paediatric population: Molecular classification and clinical associations.

Authors:  Elan Hahn; Juan Putra
Journal:  World J Gastroenterol       Date:  2020-05-21       Impact factor: 5.742

5.  Malignant transformation of hepatocellular adenoma.

Authors:  Céline Julien; Brigitte Le Bail; Laurence Chiche; Charles Balabaud; Paulette Bioulac-Sage
Journal:  JHEP Rep       Date:  2022-01-07

Review 6.  Etiology, Pathogenesis, Diagnosis, and Practical Implications of Hepatocellular Neoplasms.

Authors:  Prodromos Hytiroglou; Paulette Bioulac-Sage; Neil D Theise; Christine Sempoux
Journal:  Cancers (Basel)       Date:  2022-07-28       Impact factor: 6.575

7.  Morphologic and Molecular Findings in Myxoid Hepatic Adenomas.

Authors:  Daniel J Rowan; Saba Yasir; Zongming E Chen; Taofic Mounajjed; Sibel Erdogan Damgard; Lisa Cummins; Lizhi Zhang; Emma Whitcomb; Vince Falck; Sanford M Simon; Aatur D Singhi; Michael S Torbenson
Journal:  Am J Surg Pathol       Date:  2021-08-01       Impact factor: 6.298

8.  Long-term outcomes following resection of hepatocellular adenomas with small foci of malignant transformation or malignant adenomas.

Authors:  Sophie Chopinet; François Cauchy; Christian Hobeika; Aurélie Beaufrère; Nicolas Poté; Olivier Farges; Safi Dokmak; Mohamed Bouattour; Maxime Ronot; Valérie Vilgrain; Valérie Paradis; Olivier Soubrane
Journal:  JHEP Rep       Date:  2021-06-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.